Effect of Repeated Intravenous Amantadine Infusions in Patients with Parkinson's Disease: An Open‐Label Pilot Study
Amantadine is an antiviral drug available in oral and intravenous forms. Oral amantadine is used to treat the motor symptoms of early Parkinson's disease (PD) and to ameliorate dyskinesia in late‐stage disease. However, the long‐term influence of intravenous amantadine on motor symptoms and dys...
Saved in:
Main Authors: | Alexander Khlebtovsky (Author), Israel Steiner (Author), Therese Treves (Author), Ruth Djaldetti (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular docking investigation of the amantadine binding to the enzymes upregulated or downregulated in Parkinson's disease
by: Mihaela Ileana Ionescu
Published: (2020) -
Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease
by: Sharma VD, et al.
Published: (2018) -
Amantadine in Treatment of Dysthymia-The Pilot Case Series Study
by: Marek Krzystanek, et al.
Published: (2023) -
Amantadine in Absence Epilepsy
by: J Gordon Millichap
Published: (1992) -
Amantadine variant - aryl conjugates that inhibit multiple M2 mutant - amantadine resistant influenza a viruses
by: Christina Tzitzoglaki, et al.
Published: (2022)